Advertisement

Advertisement

BCDA Stock Latest News

BioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target

RatingsBioCardia: Advancing Regulatory Momentum in Helix Catheter and CardiAMP HF Programs Supports Buy Rating and Unchanged $25 Price Target

BioCardia gets FDA confirmation of Helix meeting minutes

PremiumThe Fly

BioCardia gets FDA confirmation of Helix meeting minutes

12d ago

BioCardia Advances Helix Catheter Toward De Novo Approval

PremiumCompany Announcements

BioCardia Advances Helix Catheter Toward De Novo Approval

12d ago

BioCardia Receives Nasdaq Notice on Minimum Bid Price

PremiumCompany Announcements

BioCardia Receives Nasdaq Notice on Minimum Bid Price

14d ago

Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability

PremiumCompany Announcements

Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability

22d ago

BioCardia Earnings Call Highlights Regulatory Momentum

PremiumCompany AnnouncementsBioCardia Earnings Call Highlights Regulatory Momentum

23d ago

BCDA Upcoming Earnings Report: What to Expect?

Pre-Earnings

BCDA Upcoming Earnings Report: What to Expect?

26d ago

BioCardia issues letter to shareholders on 2026 priorities

The Fly

BioCardia issues letter to shareholders on 2026 priorities

3M ago

BioCardia Outlines 2026 CardiAMP Strategy and Milestones

PremiumCompany Announcements

BioCardia Outlines 2026 CardiAMP Strategy and Milestones

3M ago

BioCardia Raises $4.4 Million to Extend Cash Runway

PremiumCompany Announcements

BioCardia Raises $4.4 Million to Extend Cash Runway

3M ago

BioCardia Gains FDA Path for CardiAMP PMA Approval

PremiumCompany Announcements

BioCardia Gains FDA Path for CardiAMP PMA Approval

3M ago

FDA confirms CardiAMP Heart Failure II Trial may support premarket approval

PremiumThe Fly

FDA confirms CardiAMP Heart Failure II Trial may support premarket approval

3M ago

BioCardia gains PMDA support for CardiAMP heart therapy

PremiumCompany AnnouncementsBioCardia gains PMDA support for CardiAMP heart therapy

3M ago

BioCardia Announces Encouraging CardiAMP Chronic Ischemia Data

Company Announcements

BioCardia Announces Encouraging CardiAMP Chronic Ischemia Data

4M ago

Biocardia Earnings Call: Promise Meets Funding Pressure

Company Announcements

Biocardia Earnings Call: Promise Meets Funding Pressure

4M ago

BioCardia Earnings Call: Progress, Promise and Cash Strain

PremiumCompany Announcements

BioCardia Earnings Call: Progress, Promise and Cash Strain

4M ago

Is BCDA a Buy, Before Earnings?

PremiumPre-Earnings

Is BCDA a Buy, Before Earnings?

4M ago

BioCardia provides update on Helix pre-submission meeting with FDA

PremiumThe Fly

BioCardia provides update on Helix pre-submission meeting with FDA

4M ago

BioCardia Secures FDA Pathways for Helix Catheter System

PremiumCompany Announcements

BioCardia Secures FDA Pathways for Helix Catheter System

4M ago

BioCardia Gains Japanese Patent for Heart3D Imaging Technology

PremiumCompany AnnouncementsBioCardia Gains Japanese Patent for Heart3D Imaging Technology

4M ago

Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/23/26?

Market News

Why Is Vanguard Total Stock Market (VTI) ETF Down Today, 4/23/26?

4M ago

BioCardia reports ‘positive’ outcome in consult with Japan’s PMDA for CardiAMP

The Fly

BioCardia reports ‘positive’ outcome in consult with Japan’s PMDA for CardiAMP

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >